88 related articles for article (PubMed ID: 21867608)
1. [Proteasome inhibitor bortezomib inducing apoptosis of K562 cells not affected by bone marrow mesenchymal stem cells in vitro].
Wang LX; Lu H; Fei XM; Wang CY; Zhu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):890-3. PubMed ID: 21867608
[TBL] [Abstract][Full Text] [Related]
2. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and SHIP gene expression in K562 cells].
Jia ZQ; Wei YT; Li AM; Cheng ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):916-9. PubMed ID: 23998585
[TBL] [Abstract][Full Text] [Related]
3. [Effect of proteasome inhibitor on migration ability and hepatocyte growth factor expression of bone marrow mesenchymal stem cells in multiple myeloma patients].
Li JX; Fei XM; Lu H; Hu HJ; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1204-8. PubMed ID: 22040972
[TBL] [Abstract][Full Text] [Related]
4. [Effects of bortezomib combined with 5-azacytidine on the apoptosis of K562 cells and expression of SHIP mRNA].
Jia ZQ; Wei YT; Wei YL; Su W; Yu CX; Tao J; Rong HQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1291-4. PubMed ID: 25338575
[TBL] [Abstract][Full Text] [Related]
5. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
[TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
7. [Effects of proteasome inhibitor bortezomib on NF-kappaB activity and ICAM-1 mRNA expression of K562 cells].
Lu SF; Lu H; Shen WY; Zhang JF; Liu P; Wang YR; Wang LX; Yang H; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1006-9. PubMed ID: 18928584
[TBL] [Abstract][Full Text] [Related]
8. The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling.
Kaiser MF; Heider U; Mieth M; Zang C; von Metzler I; Sezer O
Eur J Haematol; 2013 Apr; 90(4):263-72. PubMed ID: 23311753
[TBL] [Abstract][Full Text] [Related]
9. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
[TBL] [Abstract][Full Text] [Related]
10. [Effect of different concentrations of bortezomib on the expression of ERK, JNK and P38 in daunorubicin-resistant K562 cells].
Fu BB; Fan Y; Hao LC; Liao AJ; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):671-5. PubMed ID: 21729547
[TBL] [Abstract][Full Text] [Related]
11. The effects of proteasome inhibitor bortezomib on a P-gp positive leukemia cell line K562/A02.
Lü S; Chen Z; Yang J; Chen L; Zhou H; Xu X; Li J; Han F; Wang J
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e123-31. PubMed ID: 19254348
[TBL] [Abstract][Full Text] [Related]
12. [Effect of co-culture of bone marrow mesenchymal stem cells and K562 cells on expression of interleukin 8].
Wang LX; Lu H; Liu P; Fei XM; Wu YJ; Wang CY; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):156-8. PubMed ID: 18315921
[TBL] [Abstract][Full Text] [Related]
13. [Bortezomib depresses osteoblast apoptosis induced by mouse myeloma cells].
Zhao H; Bai QX; Huang GS; Yang LJ; Yue P; Zhang XY; Wang L; Fan LN; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1186-91. PubMed ID: 21129258
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of converting K562/DNR cellular drug-resistance by bortezomib.
Li YC; Wang HH; Liao AJ; Fu BB; Zhang R; Li J; Yang Y; Liu ZG; Yang W
Eur Rev Med Pharmacol Sci; 2014; 18(10):1465-72. PubMed ID: 24899604
[TBL] [Abstract][Full Text] [Related]
15. [Bortezomib-induced BiP expression and apoptosis in multiple myeloma cells].
Dong HJ; Chen XQ; Gao GX; Gu HT; Pan YZ; Gao Y; Zhu HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):107-10. PubMed ID: 19236758
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
Iwata S; Yano S; Ito Y; Ushijima Y; Gotoh K; Kawada J; Fujiwara S; Sugimoto K; Isobe Y; Nishiyama Y; Kimura H
Int J Cancer; 2011 Nov; 129(9):2263-73. PubMed ID: 21170988
[TBL] [Abstract][Full Text] [Related]
17. [Effects of arsenic trioxide combined with bortezomib on proliferation and apoptosis of K562 cells and their mechanism].
Wu HY; Wang SM; Huang JQ; Hao LM; Li XM; Wei LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1361-4. PubMed ID: 23257433
[TBL] [Abstract][Full Text] [Related]
18. [Influence of human mesenchymal stem cells on cell proliferation and chemo-sensitivity of K562 cells].
Lin YM; Bu LM; Yang SJ; Gao S; Zhang GZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):308-12. PubMed ID: 16638204
[TBL] [Abstract][Full Text] [Related]
19. [Effects of acute lymphoblastic leukemia children bone marrow mesenchymal stem cells on drug resistance of K562/A02 cell line].
Wang ZX; Yang ZM; Zou YW; Li MM; Chen FX; Zhong GY; Guan JM; Wei FG; Wu SZ; He ZT; Wu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):19-23. PubMed ID: 21362214
[TBL] [Abstract][Full Text] [Related]
20. [Effect of bortezomib on MAPK signaling pathway of K562/DNR cells].
Liao AJ; Fu BB; Wang HH; Li YC; Yao K; Zhang R; Yang W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1460-3. PubMed ID: 21176351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
